Preimplantation Genetic Testing is a test performed by an embryologist in which one or two cells are removed from an embryo. The removed cells are then screened for genetic abnormalities. This procedure may be performed in conjunction with IVF.
In Vitro Fertilization Accounts for 1.5% of Births in the USA
ASRM President Rebecca Sokol, MD, MPH Visits NYC and DC to Represent the Society
ASRM Plenary Speaker Reports Birth Following Uterine Transplant
Most Americans Approve of Preimplantation Genetic Diagnosis Used to Avoid Disease, But Not for Designing a Baby
Uterine Lavage Shows Promise for Performing PGD and PGS without IVF
Pérdida recurrente del embarazo (Recurrent preganancy loss)
Riesgos de la fertilización in vitro (Risks of IVF)
Use of preimplantation genetic diagnosis for serious adult onset conditions
Coding for single-gene defects
Journal of Assisted Reproduction and Genetics
Q13. Should we have genetic testing?
Infertility treatments, including IVF and similar procedures, account for approx 0.07 percent of U.S. health care costs
Genetic Screening for Birth Defects
Recurrent Pregnancy Loss
Age and Fertility
SRBT Salary Survey
Preimplantation genetic testing
Members are allowed to have direct input in shaping policies and protocols in their area of expertise through ASRM affiliated societies, professional groups, and special interest groups.
Affiliates: SART | SMRU | SREI | SRBT | SRS
Professional Groups: ARM | LPG | MHPG | NPG
Special Interest Groups: AESIG | CAMSIG | ChSIG | CSIG | EndoSIG | EPSIG | ERSIG | FPSIG | FSIG | HDSIG | GCSIG | IRMSIG | MSIG | NutriSIG | PAGSIG | PGDSIG | RISIG | RMSCBSIG | TSIG | WC
©1996 - 2015 ASRM, American Society for Reproductive Medicine. All Rights Reserved.